| ADTX 0.0109 -15.50% | GDC 0.0281 -73.26% | SOXS 4.63 17.22% | OBAI 1.11 107.63% | TZA 4.17 2.71% | IVDA 0.515 62.87% | GPUS 0.26 -4.17% | SPCX 201.8 4.83% | SUGP 1.11 26.06% | BITO 8.92 -1.44% | CRVO 4.52 82.26% | YYGH 0.141 11.73% | SRXH 0.19 21.02% | AAL 15.71 1.62% | INTC 117.05 -8.45% | NVDA 207.41 -2.37% | CCTG 1.48 89.89% | NOK 13.975 -5.70% | SOFI 17.71 3.39% | WOK 0.0507 -40.84% | NIVF 0.7 20.42% | PAVS 0.193 1.63% | SNAP 5.16 -9.63% | IMCC 0.26 -0.38% | RXT 6.21 4.99% | TQQQ 79.93 -5.51% | OPEN 4.75 3.04% | NFLX 78.72 -3.61% | SPY 750.33 -0.60% | GRAB 3.49 0.87% | MRVL 278.67 -9.78% | KEEL 5.9401 4.95% | ACHR 5.44 -1.98% | BEEM 1.32 11.86% | TSLL 13.45 -3.17% | SMCI 29.22 -5.28% | SOXL 226.19 -16.99% | SQQQ 38.35 5.62% | ONDS 9.21 -3.15% | BTBT 2.04 5.70% | AMC 2.49 9.21% | NU 12.72 2.33% | JOBY 9.34 -3.41% | ALIT 0.6165 -6.86% | QQQ 729.86 -1.90% | MU 1020.76 -6.18% | NVD 4.89 4.94% | NIO 5.01 -3.65% | PLUG 2.71 -3.21% | CRWV 117.03 9.67%

Procter & Gamble Reports Flat Organic Sales as U.S. Spending Remains Pressured

Procter & Gamble (NYSE: PG) reported flat organic sales growth for its fiscal second quarter, as the consumer products giant faced a challenging spending environment in the United States.

The company said organic sales, which exclude the impact of foreign exchange and acquisitions or divestitures, were unchanged for the quarter ended December. Bloomberg consensus estimates had called for growth of 0.54%.

P&G noted that price increases were fully offset by an equal decline in volumes. Strength in the company’s beauty and health care segments was offset by weaker performance in grooming, home care and baby care.

Net sales increased 1% year over year to $22.2 billion, slightly below Wall Street expectations of $22.32 billion.

Core earnings per share were $1.88, unchanged from the prior year and modestly above analyst projections of $1.86.

Published on: January 22, 2026